Physician profile
Terry L Goodman
NPI 1831235498
$1,669.71
in general payments reported to CMS, 2019-2025
10 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $185 · 2021: $13.85 · 2022: $99.47 · 2023: $247 · 2024: $497 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $336.17 | 2019-2024 | Dailies Total1, Total30 |
| Johnson & Johnson Vision Care, INC. | $274.91 | 2019-2020 | |
| Genentech USA, INC. | $246.60 | 2023 | Vabysmo |
| Abb Con-Cise Optical Group LLC | $182.24 | 2019-2022 | |
| Harrow Eye, LLC | $144.67 | 2024 | Vevye |
| Coopervision INC. | $144.10 | 2024 | Myday Contact Lens |
| Astellas Pharma US INC | $119.70 | 2025 | Izervay |
| Johnson & Johnson Surgical Vision, INC. | $102.95 | 2019 | |
| Glaukos Corporation | $71.62 | 2022 | |
| Biotissue Holdings INC. | $46.75 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.